Norquest Fe

   
Google
 
Web NewDrugInformation.com

Norquest Fe


Drug - Norquest Fe
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ethinyl Estradiol; Ferrous Fumarate; Norethindrone
Multiple ingredients are in alphabetical order.

Strength - 0.035MG;75MG;1MG
The potency of the active ingredient(s), Ethinyl Estradiol; Ferrous Fumarate; Norethindrone. May repeat for multiple part products.

Applicant - GD SEARLE LLC
The firm name holding legal responsibility for Norquest Fe. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018926
The FDA assigned number to Norquest Fe. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Norquest Fe. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 18, 1986
The date Norquest Fe was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Norquest Fe. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Norquest Fe is in. Format is RX, OTC, DISCN.

Applicant Full Name - Gd Searle Llc
The full name of the firm holding legal responsibility for the new application of Norquest Fe.

Norquest Fe